EPISODE · Aug 30, 2022 · 11 MIN
State-of-the-art genetics panel optimizes kidney disease treatment: Linnea M. Baudhuin, Ph.D., and Emily K. Thoreson, M.S., CGC
from Answers from the Lab · host Mayo Clinic Laboratories
(00:31) Would each of you share a little about yourselves and your backgrounds?(01:17) Could you please provide us with an overview of what types of genetic testing for inherited kidney diseases are available Mayo Clinic Labs?(02:35) Can you expand on why genetic testing for kidney disease is important?(04:30) Who could benefit from genetic testing for inherited kidney diseases?(05:55) What types of variants are detected by these new genetic panels at Mayo Clinic Labs?(07:05) How would you say our test matches up to other tests that are currently available?(08:07) What other unique features set the Mayo test apart from some of the competitor offerings?(09:08) Could you summarize the benefits of doing genetic testing for kidney diseases at Mayo Clinic?(10:01) How can a healthcare provider order one of these new inherited kidney disease genetic test panels, and what types of specimens do we accept?
What this episode covers
Linnea M. Baudhuin, Ph.D., and Emily K. Thoreson, M.S., CGC, explain how Mayo Clinic Laboratories renal genetics testing provides comprehensive, accurate and actionable results. Identifying a genetic cause helps guide the complex decisions involved with treating kidney disease.
NOW PLAYING
State-of-the-art genetics panel optimizes kidney disease treatment: Linnea M. Baudhuin, Ph.D., and Emily K. Thoreson, M.S., CGC
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m